Brief: SynAct: Shareholding Board, Management Sign Lock-Up Agreements
15/06/2026 06:33
BRIEF-SynAct: Shareholding Board, Management Sign Lock-Up Agreements June 15 (Reuters) - SynAct Pharma AB SYNACT.ST:
ALL SHAREHOLDING BOARD AND MANAGEMENT SIGN LOCK-UP AGREEMENTS UNTIL DECEMBER 31, 2026
MANAGEMENT AND BOARD COMMIT NOT TO SELL SHARES OR SECURITIES UNTIL DECEMBER 31, 2026
Source text: ID:nMFN13vV62
Further company coverage: SYNACT.ST
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))
Recent news on SynAct Pharma AB
See all newsSweden's SynAct Pharma Q3 net loss narrows as expenses fall
Brief: SynAct Pharma Q3 Net Income SEK -32.177 Million
Brief: SynAct Pharma Signs First Commercial Partnership For Resomelagon
Brief: WHO Names Resomelagon Among Key Dengue Drug Candidates
Brief: SynAct Pharma Says Advance Analysis Supports Phase 3 Development